Diana Brainard - 19 Oct 2023 Form 4 Insider Report for Allovir, Inc. (ALVR)

Role: Chief Executive Officer, Director
Signature: /s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol: ALVR
Transactions as of: 19 Oct 2023
Net transactions value: -$13,558
Form type: 4
Filing time: 23 Oct 2023, 17:00:11 UTC
Previous filing: 05 Oct 2023
Next filing: 21 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALVR	Common Stock	Sale	$13,558	-8,581	-0.96%	$1.58	881,977	19 Oct 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.